Literature DB >> 20821043

Prolonged gonadotropin stimulation is associated with decreased ART success.

Meleen Chuang1, Athena Zapantis, Martina Taylor, Sangita K Jindal, Genevieve S Neal-Perry, Harry J Lieman, Alex Joel Polotsky.   

Abstract

PURPOSE: to evaluate whether the duration of gonadotropin stimulation predicts the likelihood of live birth after ART.
METHODS: all IVF or ICSI cycles using fresh autologous oocytes at our institution between January 2004 and December 2007 were analyzed.
RESULTS: out of 699 cycles resulting in oocyte retrieval, 193 produced a live birth (27.6%). Women who achieved a live birth had a significantly shorter stimulation phase (11.1 vs. 11.5 days, respectively). Multivariable analysis suggested that 13 days or longer of stimulation decreased the likelihood of a live birth by 53% as compared to cycles that were 10-12 days long (odds ratio [OR] 0.47; 95% confidence interval [CI]: 0.30-0.75) after adjustment for female age, maximum historical FSH, total dose of gonadotropin received, oocytes retrieved, embryos transferred, antagonist suppression and PCOS diagnosis.
CONCLUSIONS: prolonged duration of gonadotropin stimulation is an independent negative predictor of ART success in our cohort.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20821043      PMCID: PMC2997954          DOI: 10.1007/s10815-010-9476-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  23 in total

1.  Impact of overweight and underweight on assisted reproduction treatment.

Authors:  Péter Fedorcsák; Per Olav Dale; Ritsa Storeng; Gudvor Ertzeid; Sverre Bjercke; Nan Oldereid; Anne K Omland; Thomas Abyholm; Tom Tanbo
Journal:  Hum Reprod       Date:  2004-08-19       Impact factor: 6.918

2.  Factors that affect outcome of in-vitro fertilisation treatment.

Authors:  A Templeton; J K Morris; W Parslow
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

3.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

4.  A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.

Authors:  E M E W Heijnen; M J C Eijkemans; E G Hughes; J S E Laven; N S Macklon; B C J M Fauser
Journal:  Hum Reprod Update       Date:  2005-08-25       Impact factor: 15.610

Review 5.  Environmental and occupational factors affecting fertility and IVF success.

Authors:  Edward V Younglai; Alison C Holloway; Warren G Foster
Journal:  Hum Reprod Update       Date:  2004-12-15       Impact factor: 15.610

6.  What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction.

Authors:  Jason K Min; Sue A Breheny; Vivien MacLachlan; David L Healy
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception.

Authors:  M Bonduelle; U-B Wennerholm; A Loft; B C Tarlatzis; C Peters; S Henriet; C Mau; A Victorin-Cederquist; A Van Steirteghem; A Balaska; J R Emberson; A G Sutcliffe
Journal:  Hum Reprod       Date:  2004-12-02       Impact factor: 6.918

8.  The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome.

Authors:  D L Hock; H Louie; R M Shelden; C V Ananth; E Kemmann
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

9.  Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels.

Authors:  J S Martin; J A Nisker; I S Tummon; S A Daniel; J L Auckland; V Feyles
Journal:  Fertil Steril       Date:  1996-06       Impact factor: 7.329

Review 10.  Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Authors:  N P Johnson; W Mak; M C Sowter
Journal:  Cochrane Database Syst Rev       Date:  2004
View more
  7 in total

1.  The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles.

Authors:  N Purandare; G Emerson; C Kirkham; C Harrity; D Walsh; E Mocanu
Journal:  Ir J Med Sci       Date:  2016-11-07       Impact factor: 1.568

2.  Association between the proportion of dominant follicles and oocyte developmental competence.

Authors:  Yi Li; Rui-Qi Li; Song-Bang Ou; Ling Ren; Ning-Feng Zhang; Li-Na Wei; Qing-Xue Zhang; Dong-Zi Yang
Journal:  J Assist Reprod Genet       Date:  2014-09-17       Impact factor: 3.412

3.  Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome.

Authors:  Amanda Ryan; Shunping Wang; Ruben Alvero; Alex J Polotsky
Journal:  J Assist Reprod Genet       Date:  2014-05-28       Impact factor: 3.412

4.  The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response.

Authors:  Lucky Sekhon; Kathryn Shaia; Anthony Santistevan; Karen Hunter Cohn; Joseph A Lee; Piraye Yurttas Beim; Alan B Copperman
Journal:  J Assist Reprod Genet       Date:  2017-03-20       Impact factor: 3.412

5.  Stimulation Duration in Patients with Early Oocyte Maturation Triggering Criteria Does Not Impact IVF-ICSI Outcomes.

Authors:  Sophie Stout; Yohann Dabi; Charlotte Dupont; Lise Selleret; Cyril Touboul; Nathalie Chabbert-Buffet; Emile Daraï; Emmanuelle Mathieu d'Argent; Kamila Kolanska
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

6.  Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and In Vitro Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Authors:  Xinyang Zhao; Xu Zhang; Shanshan Wu; Jichun Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

Review 7.  Ovarian Stimulation in Assisted Reproductive Technology Cycles for Varied Patient Profiles: An Indian Perspective.

Authors:  Padma Rekha Jirge; Madhuri Milind Patil; Rohit Gutgutia; Jatin Shah; Mridubhashini Govindarajan; Varsha Samson Roy; Nalini Kaul-Mahajan; Faddy I Sharara
Journal:  J Hum Reprod Sci       Date:  2022-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.